Awarded
Insulin aspart 300 E. in 3 ml Lsg. Injektionslösung in einem Fertigpen St a 3 ml
- Buyer
- PBMG eG
- Winners
- Novo Nordisk Pharma GmbH
- Contract value
- no value published
- Bids received
- 2
- Published
- 2 Mar 2026
- Awarded
- 5 Jan 2026
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)